Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Schreiber

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Cancer Immunity|April 7, 2005
Cancer vaccines 2004 opening address: the molecular and cellular basis of cancer immunosurveillance and immunoeditingRobert D Schreiber
Advances in Immunology|March 1, 2016
PrefaceRobert D Schreiber
Annual Review of Medicine|January 27, 2026
Cancer Neoantigen Vaccines Emerge EfficaciousHussein Sultan, Robert D Schreiber
Annals of the New York Academy of Sciences|May 9, 2013
Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapyMatthew D Vesely, Robert D Schreiber
Current Opinion in Immunology|February 13, 2007
Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?Jack D Bui, Robert D Schreiber
Science (New York, N.Y.)|October 10, 2015
CANCER. The odds of immunotherapy successMatthew M Gubin, Robert D Schreiber
Cancer Immunology Research|January 3, 2023
Cancer Immunology Research: A Decade of Illumination and InnovationRobert D Schreiber, Philip D Greenberg
Immunologic Research|August 18, 2005
The continuing evolution of immunology at Washington UniversityPaul M Allen, Robert D Schreiber
Cancer Immunology Research|January 5, 2022
A New Year, A New InitiativeRobert D Schreiber, Philip D Greenberg
Science (New York, N.Y.)|April 4, 2015
Neoantigens in cancer immunotherapyTon N Schumacher, Robert D Schreiber
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Cancer Immunity|April 7, 2005
Cancer vaccines 2004 opening address: the molecular and cellular basis of cancer immunosurveillance and immunoeditingRobert D Schreiber
Advances in Immunology|March 1, 2016
PrefaceRobert D Schreiber
Annual Review of Medicine|January 27, 2026
Cancer Neoantigen Vaccines Emerge EfficaciousHussein Sultan, Robert D Schreiber
Annals of the New York Academy of Sciences|May 9, 2013
Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapyMatthew D Vesely, Robert D Schreiber
Current Opinion in Immunology|February 13, 2007
Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?Jack D Bui, Robert D Schreiber
Science (New York, N.Y.)|October 10, 2015
CANCER. The odds of immunotherapy successMatthew M Gubin, Robert D Schreiber
Cancer Immunology Research|January 3, 2023
Cancer Immunology Research: A Decade of Illumination and InnovationRobert D Schreiber, Philip D Greenberg
Immunologic Research|August 18, 2005
The continuing evolution of immunology at Washington UniversityPaul M Allen, Robert D Schreiber
Cancer Immunology Research|January 5, 2022
A New Year, A New InitiativeRobert D Schreiber, Philip D Greenberg
Science (New York, N.Y.)|April 4, 2015
Neoantigens in cancer immunotherapyTon N Schumacher, Robert D Schreiber
Pageof 14